Interventional Cardiologists archivos | Page 28 of 43

Chronic Ischemic cardiopathy

High doses of statins may reduce the lipid content in severe injury

Original title: Changes in Plaque Lipid Content After Short-Term Intensive Versus Standard Statin Therapy. The YELLOW Trial (Reduction...

solaci - 15 July, 2013

Learn More

Interventional Cardiologists

Percutaneous Left Atrial Appendage Closure With the AMPLATZER : a valid alternative when anticoagulation is contraindicated

Original title: Percutaneous Left Atrial Appendage Closure With the AMPLATZER Cardiac Plug Device in Patients With Nonvalvular Atrial...

solaci - 10 July, 2013

Learn More

Interventional Cardiologists

Thoracoscopic Stand-Alone Left Atrial Appendectomy

Original title: Thoracoscopic Stand-Alone Left Atrial Appendectomy for Thromboembolism Prevention in Nonvalvular Atrial Fibrilation. Reference: Toshiya Ohtsuka, et al. J...

solaci - 10 July, 2013

Learn More

Acute coronary syndromes

DES versus Bare in primary angioplasty at five years. Initial advantage is reducing

Original: title Long-Term Outcome After Drug-Eluting VersusBare-Metal Stent Implantation in Patients WithST-Segment Elevation Myocardial Infarction. 5 Years Follow-Up...

solaci - 5 July, 2013

Learn More

Acute coronary syndromes

The Importance of TIMI 3 flow in primary angioplasty

Original title: Predicitors of suboptimal TIMI flow alter primary angioplasty for acute myocardial infarction: results from the HORIZON-AMI...

solaci - 5 July, 2013

Learn More

Carotid

Asymptomatic carotid injury, a disease not so silent

Original title: Association of the Recovery of Objective Abnormal CerebralPerfusion with Neurocognitive Improvement after CarotidRevascularization. Reference: Ching-Chang Huanget al. J...

solaci - 4 July, 2013

Learn More

Acute coronary syndromes

Monoclonal antibodies to decrease peri-procedural myocardial damage

Original title: Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention for Non–ST-Segment Elevation...

solaci - 3 July, 2013

Learn More

Antiplatelet

Rational use of bivalirudin, less bleeding and less costs using risk score

Original title: Pre-Procedural Estimate of Individualized Bleeding Risk Impacts Physicians’ Utilization of Bivalirudin During Percutaneous Coronary Intervention. Reference: Seshu C....

solaci - 2 July, 2013

Learn More

Interventional Cardiologists

High doses of statins may reduce the lipid content in severe injury

Percutaneous Left Atrial Appendage Closure With the AMPLATZER : a valid alternative when anticoagulation is contraindicated

Thoracoscopic Stand-Alone Left Atrial Appendectomy

DES versus Bare in primary angioplasty at five years. Initial advantage is reducing

The Importance of TIMI 3 flow in primary angioplasty

Asymptomatic carotid injury, a disease not so silent

Monoclonal antibodies to decrease peri-procedural myocardial damage

Rational use of bivalirudin, less bleeding and less costs using risk score

Last News

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Institutional News

Check out the best images of the El Salvador 2024 Sessions

The El Salvador 2024 Sessions are coming soon

Check out the best images of the Arequipa 2024 Sessions

Access